Literature DB >> 9166944

Overexpression of p53 protein during pancreatitis.

H Maacke1, A Kessler, W Schmiegel, C Roeder, I Vogel, W Deppert, H Kalthoff.   

Abstract

Overexpression of p53 correlates with neoplasia in many cytological specimens. To test the specificity of overexpressed p53 as a tumour marker for the detection of pancreatic cancer, we analysed cytological specimens of pancreatic juice samples from patients with pancreatitis or pancreatic carcinoma (n = 42) for p53 protein overexpression. p53 protein overexpression was found in 59% of patients with pancreatitis and 67% of patients with pancreatic carcinoma. Thus, the assessment of p53 protein overexpression is not useful in the diagnosis of pancreatic cancer. Overexpressed p53 during pancreatitis appears to be wild-type p53. Overexpression of p53 may result from DNA damage occurring during chronic inflammation. It is well established that p53 can induce apoptosis upon DNA damage. Consequently, we found apoptotic cell death in five out of five tested cytological preparations from patients with pancreatitis as well as in one out of one pancreatic carcinoma specimen.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9166944      PMCID: PMC2223499          DOI: 10.1038/bjc.1997.256

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  17 in total

1.  Cancer. p53, guardian of the genome.

Authors:  D P Lane
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

2.  Detection of c-K-ras mutations in fine needle aspirates from human pancreatic adenocarcinomas.

Authors:  D Shibata; C Almoguera; K Forrester; J Dunitz; S E Martin; M M Cosgrove; M Perucho; N Arnheim
Journal:  Cancer Res       Date:  1990-02-15       Impact factor: 12.701

3.  Immunochemical characterization and quantitative distribution of pancreatic stone protein in sera and pancreatic secretions in pancreatic disorders.

Authors:  W Schmiegel; M Burchert; H Kalthoff; C Roeder; G Bützow; H Grimm; B Kremer; N Soehendra; H W Schreiber; H G Thiele
Journal:  Gastroenterology       Date:  1990-11       Impact factor: 22.682

4.  High levels of p53 protein in UV-irradiated normal human skin.

Authors:  P A Hall; P H McKee; H D Menage; R Dover; D P Lane
Journal:  Oncogene       Date:  1993-01       Impact factor: 9.867

5.  Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group.

Authors:  A B Lowenfels; P Maisonneuve; G Cavallini; R W Ammann; P G Lankisch; J R Andersen; E P Dimagno; A Andrén-Sandberg; L Domellöf
Journal:  N Engl J Med       Date:  1993-05-20       Impact factor: 91.245

6.  DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1.

Authors:  S A Hahn; M Schutte; A T Hoque; C A Moskaluk; L T da Costa; E Rozenblum; C L Weinstein; A Fischer; C J Yeo; R H Hruban; S E Kern
Journal:  Science       Date:  1996-01-19       Impact factor: 47.728

7.  p53 and K-RAS alterations in pancreatic epithelial cell lesions.

Authors:  H Kalthoff; W Schmiegel; C Roeder; D Kasche; A Schmidt; G Lauer; H G Thiele; G Honold; K Pantel; G Riethmüller
Journal:  Oncogene       Date:  1993-02       Impact factor: 9.867

8.  Frequent codeletion of p16/MTS1 and p15/MTS2 and genetic alterations in p16/MTS1 in pancreatic tumors.

Authors:  M Naumann; N Savitskaia; C Eilert; A Schramm; H Kalthoff; W Schmiegel
Journal:  Gastroenterology       Date:  1996-04       Impact factor: 22.682

9.  Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.

Authors:  Y Gavrieli; Y Sherman; S A Ben-Sasson
Journal:  J Cell Biol       Date:  1992-11       Impact factor: 10.539

10.  Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer.

Authors:  C M Barton; S L Staddon; C M Hughes; P A Hall; C O'Sullivan; G Klöppel; B Theis; R C Russell; J Neoptolemos; R C Williamson
Journal:  Br J Cancer       Date:  1991-12       Impact factor: 7.640

View more
  14 in total

1.  PTGF-beta, a type beta transforming growth factor (TGF-beta) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-beta signaling pathway.

Authors:  M Tan; Y Wang; K Guan; Y Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

2.  Towards immunotherapy of pancreatic cancer.

Authors:  I F McKenzie; V Apostolopoulos
Journal:  Gut       Date:  1999-06       Impact factor: 23.059

3.  Staining for p53 and Ki-67 increases the sensitivity of EUS-FNA to detect pancreatic malignancy.

Authors:  Alexander W Jahng; Sonya Reicher; David Chung; Donna Varela; Rahul Chhablani; Anil Dev; Binh Pham; Jose Nieto; Rose J Venegas; Samuel W French; Bruce E Stabile; Viktor E Eysselein
Journal:  World J Gastrointest Endosc       Date:  2010-11-16

4.  Histological evaluation of preoperative biopsies from ampulla vateri.

Authors:  Gábor Elek; Sándor Gyôri; Bernadett Tóth; Akos Pap
Journal:  Pathol Oncol Res       Date:  2003-04-18       Impact factor: 3.201

5.  Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinoma.

Authors:  E Heinmöller; W Dietmaier; H Zirngibl; P Heinmöller; W Scaringe; K W Jauch; F Hofstädter; J Rüschoff
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

6.  Morphological and immunohistochemical characterization of isolated tumor cells by p53 status in gastrointestinal tumors.

Authors:  C Milsmann; L Füzesi; E Heinmöller; P Krause; C Werner; H Becker; O Horstmann
Journal:  Langenbecks Arch Surg       Date:  2007-09-18       Impact factor: 3.445

Review 7.  Pancreatic cancer: role of the immune system in cancer progression and vaccine-based immunotherapy.

Authors:  Amedeo Amedei; Elena Niccolai; Domenico Prisco
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 8.  Advances in inducing adaptive immunity using cell-based cancer vaccines: Clinical applications in pancreatic cancer.

Authors:  Mikio Kajihara; Kazuki Takakura; Tomoya Kanai; Zensho Ito; Yoshihiro Matsumoto; Shigetaka Shimodaira; Masato Okamoto; Toshifumi Ohkusa; Shigeo Koido
Journal:  World J Gastroenterol       Date:  2016-05-14       Impact factor: 5.742

9.  Mitochondrial dysfunction and apoptosis of acinar cells in chronic pancreatitis.

Authors:  Lipi Singh; Dapinder K Bakshi; Siddarth Majumdar; Sunil Kumar Arora; Rakesh Kumar Vasishta; Jai Dev Wig
Journal:  J Gastroenterol       Date:  2008-07-04       Impact factor: 7.527

Review 10.  What is recent in pancreatic cancer immunotherapy?

Authors:  Elena Niccolai; Domenico Prisco; Mario Milco D'Elios; Amedeo Amedei
Journal:  Biomed Res Int       Date:  2012-12-26       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.